Development of Robust Cationic Light-Activated Thermosensitive Liposomes: Choosing the Right Lipids.

cationic liposomes light activation membrane fluidity molecular dynamics simulations stimuli-responsive release thermosensitive

Journal

Molecular pharmaceutics
ISSN: 1543-8392
Titre abrégé: Mol Pharm
Pays: United States
ID NLM: 101197791

Informations de publication

Date de publication:
06 11 2023
Historique:
medline: 7 11 2023
pubmed: 24 10 2023
entrez: 24 10 2023
Statut: ppublish

Résumé

Extensive research has been conducted on cationic light-activated thermosensitive liposomes (CLTSLs) as a means for site-specific and controlled drug release; however, less attention has been given to the stability of these nanoparticles. Selecting the appropriate lipids is crucial for the development of a stable and responsive system. In this study, we investigated the impact of various lipids on the physical properties of cationic light-activated liposomes. Incorporating poly(ethylene glycol) PEG molecules resulted in uniform liposomes with low polydispersity index, while the addition of unsaturated lipid (DOTAP) resulted in extremely leaky liposomes, with almost 80% release in just 10 min of incubation at body temperature. Conversely, the inclusion of cholesterol in the formulation increased liposome stability too much and decreased their sensitivity to stimuli-responsive release, with only 14% release after 2 min of light exposure. To achieve stable and functional CLTSL, we substituted an equivalent amount of unsaturated lipid with a saturated lipid (DPTAP), resulting in stable liposomes at body temperature that were highly responsive to light, releasing 90% of their content in 10 s of light exposure. We also conducted two atomistic molecular dynamics simulations using lipid compositions with saturated and unsaturated lipids to investigate the effect of lipid composition on the dynamical properties of the liposomal lipid bilayer. Our findings suggest that the nature of lipids used to prepare liposomes significantly affects their properties, especially when the drug loading needs to be stable but triggered drug release properties are required at the same time. Selecting the appropriate lipids in the right amount is therefore essential for the preparation of liposomes with desirable properties.

Identifiants

pubmed: 37874965
doi: 10.1021/acs.molpharmaceut.3c00602
pmc: PMC10630945
doi:

Substances chimiques

Liposomes 0
Lipid Bilayers 0
Polyethylene Glycols 3WJQ0SDW1A

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5728-5738

Références

Chem Phys Lipids. 2015 Jan;185:88-98
pubmed: 25087883
ACS Appl Mater Interfaces. 2022 Jul 20;14(28):31525-31540
pubmed: 35790214
J Comput Chem. 2010 Mar;31(4):671-90
pubmed: 19575467
Pharmaceutics. 2021 Jun 27;13(7):
pubmed: 34199018
Nanoscale. 2017 Aug 10;9(31):11103-11118
pubmed: 28741634
Acta Biomater. 2017 Oct 15;62:157-166
pubmed: 28827183
Colloids Surf A Physicochem Eng Asp. 2022 May 20;641:
pubmed: 35295084
Biochimie. 2013 Nov;95(11):2018-33
pubmed: 23871914
Nano Lett. 2013 Jun 12;13(6):2324-31
pubmed: 22616659
Appl Microbiol Biotechnol. 2021 Jan;105(2):525-538
pubmed: 33394152
J Pharm Sci. 2010 Jun;99(6):2839-53
pubmed: 20091826
Biochim Biophys Acta. 2001 May 2;1512(1):27-39
pubmed: 11334622
J Chem Theory Comput. 2011 Oct 11;7(10):3162-3180
pubmed: 22125473
Sci Rep. 2015 Sep 24;5:14258
pubmed: 26400780
Br J Clin Pharmacol. 2014 Jun;77(6):998-1010
pubmed: 24134216
Mol Pharm. 2016 Jun 6;13(6):2095-107
pubmed: 27097108
Cancer. 2009 Aug 1;115(15):3475-82
pubmed: 19536896
Biomaterials. 2010 May;31(13):3657-66
pubmed: 20138662
Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3654-8
pubmed: 19225105
J Clin Oncol. 1995 Apr;13(4):996-1003
pubmed: 7707129
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
Langmuir. 2012 Sep 4;28(35):12851-60
pubmed: 22873775
Int J Pharm. 2013 Aug 30;453(1):225-32
pubmed: 22766442
J Chem Theory Comput. 2012 Feb 14;8(2):759-776
pubmed: 22685386
J Control Release. 2015 Dec 10;219:31-42
pubmed: 26208426
Cancer Res. 2002 Nov 1;62(21):6132-40
pubmed: 12414638
Pharmaceutics. 2020 Aug 12;12(8):
pubmed: 32806740
Pharmaceutics. 2022 Feb 28;14(3):
pubmed: 35335920
ACS Appl Mater Interfaces. 2018 May 2;10(17):14426-14437
pubmed: 29651836
ACS Appl Mater Interfaces. 2020 Jan 8;12(1):151-162
pubmed: 31820904
J Control Release. 2018 Aug 28;284:213-223
pubmed: 29964133
J Comput Chem. 2008 Aug;29(11):1859-65
pubmed: 18351591
ACS Nano. 2011 Jun 28;5(6):4919-26
pubmed: 21591812
Adv Drug Deliv Rev. 2022 Aug;187:114395
pubmed: 35709884
J Control Release. 2016 Dec 28;244(Pt B):157-166
pubmed: 27565215
Int J Pharm. 2012 Jul 1;430(1-2):328-34
pubmed: 22525086
J Phys Chem B. 2007 Aug 23;111(33):10032-9
pubmed: 17663578
Theranostics. 2016 Oct 1;6(13):2337-2351
pubmed: 27877239
Biophys J. 2010 Sep 8;99(5):1342-9
pubmed: 20816045
Food Chem Toxicol. 2018 Mar;113:40-48
pubmed: 29337230
Mol Pharm. 2012 Mar 5;9(3):514-22
pubmed: 22332810
Biochemistry. 2014 Mar 4;53(8):1275-83
pubmed: 24512123
Int J Pharm. 2014 Nov 20;475(1-2):408-15
pubmed: 25218394
Heliyon. 2018 Dec 26;4(12):e01088
pubmed: 30603716
Biochim Biophys Acta. 2000 Mar 15;1464(1):151-64
pubmed: 10704929
J Phys Chem B. 2011 Dec 29;115(51):15241-50
pubmed: 22081997

Auteurs

Puja Gangurde (P)

Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, FI-00790 Helsinki, Finland.

Mohammad Mahmoudzadeh (M)

Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, FI-00790 Helsinki, Finland.

Zahra Gounani (Z)

Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, FI-00790 Helsinki, Finland.

Artturi Koivuniemi (A)

Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, FI-00790 Helsinki, Finland.

Patrick Laurén (P)

Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, FI-00790 Helsinki, Finland.

Tatu Lajunen (T)

Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, FI-00790 Helsinki, Finland.
School of Pharmacy, University of Eastern Finland, P.O. Box 1627, FI-70211 Kuopio, Finland.

Timo Laaksonen (T)

Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, FI-00790 Helsinki, Finland.
Faculty of Engineering and Natural Sciences, Tampere University, FI-33101 Tampere, Finland.

Articles similaires

Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Tumor Microenvironment Nanoparticles Immunotherapy Cellular Senescence Animals
Cobalt Azo Compounds Ferric Compounds Polyesters Photolysis
Neoplastic Stem Cells Animals Humans Aldehyde Dehydrogenase Tretinoin

Classifications MeSH